Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review.

MLA

McAllister, Mark A., et al. “Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review.” Journal of Vitreoretinal Diseases, vol. 7, no. 2, Dec. 2022, pp. 144–53. EBSCOhost, https://doi.org/10.1177/24741264221135799.

APA

McAllister, M. A., Moore, S. M., Bullock, B., & Christoforidis, J. B. (2022). Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review. Journal of Vitreoretinal Diseases, 7(2), 144–153. https://doi.org/10.1177/24741264221135799

Chicago

McAllister, Mark A, Spencer M Moore, Brenna Bullock, and John B Christoforidis. 2022. “Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review.” Journal of Vitreoretinal Diseases 7 (2): 144–53. doi:10.1177/24741264221135799.